Please assess the completion status of the following clinical trial:

Trial Title: Azithromycin in Bronchiolitis Obliterans Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stable LTx recipients at discharge after transplantation.~* Signed informed consent~* Adult (age at least 18 years old at moment of transplantation)~* Able to take oral medication~Exclusion Criteria:~* Prolonged and/or complicated ICU-course after transplantation.~* Early (\<30 days post-transplant) post-operative death~* Major suture problems (airway stenosis or stent)~* Retransplantation (lung)~* Previous transplantation (solid organ)~* Multi-organ transplantation (lung+ other solid organ)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Azithromycin (Type: EXPERIMENTAL): 250 mg daily for 5 days, followed by 250 mg three times a week (Mon.-Wed.-Fri.) until the end of study
- Placebo (Type: PLACEBO_COMPARATOR): PLacebo daily for 5 days, followed by placebo three times a week (Mon.-Wed.-Fri.) until end of study.

Based on this trial design, predict the completion outcome and termination type (if applicable).